Division of Nephrology and Hypertension

February 5, 2026

‘Liberation’ from acute dialysis may enhance recovery of kidney function

Researchers at Vanderbilt Health and three other centers compared conventional dialysis to a conservative dialysis strategy.

By Guillermo Sanchez, PhD
February 4, 2026

Vanderbilt’s Vineet Agrawal, Fabian Bock among 2026 ASCI Young Physician-Scientist awardees

Since 2014, 27 Vanderbilt faculty members have received the annual award, which recognizes “notable achievements” by researchers early in their first faculty appointments.

By Bill Snyder
Joshua Carty, MD
July 23, 2025

VUMC nephrology fellow Joshua Carty wins grant to study rare kidney disorder

Carty’s research focuses on nephrogenic diabetes insipidus, a rare kidney condition in which the body produces too much urine, leading to potentially dangerous dehydration.

By Bill Snyder
Raymond Harris, MD, left, and Ming-Zhi Zhang, MD, MSc, in the lab. (photo by John Russell)
May 20, 2025

VUMC discovery one step closer to treatment for kidney fibrosis

Study shows that deletion of EGFR from myeloid cells accelerated recovery from acute kidney injury and reduced subsequent fibrosis.

By Bill Snyder
January 23, 2025

Elite society honors two VUMC physician-scientists

The Young Physician-Scientist Award recognizes “notable achievements” by researchers who are within five years of their first faculty appointment.

By Bill Snyder
October 25, 2024

Blockbuster obesity drugs also may slow kidney disease

The report supports previous clinical trials that found the GLP-1 receptor agonist drug semaglutide reduced kidney disease progression in patients with Type 2 diabetes.

By Bill Snyder
August 5, 2024

Low potassium ‘turns on’ kidney proximal tubule: study

A kidney protein that responds to low levels of blood potassium — which can cause high blood pressure and cardiovascular problems — may be a target for new therapeutics.
By Leigh MacMillan
March 25, 2024

VUMC team finds potential treatment for kidney fibrosis

By Bill Snyder
March 7, 2024

Blood mutations increase risk for acute kidney injury: study

A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide.
By Bill Snyder
March 4, 2024

Vanderbilt’s Yash Choksi and Fabian Bock honored by the Southern Society for Clinical Investigation

Vanderbilt's Yash Choksi, MD, recently received the 2024 Research Investigator Early Career Faculty Award from the Southern Society for Clinical Investigation and Fabian Bock, MD, PhD, won the society's Research Scholar Award.
By Bill Snyder
February 7, 2024

VUMC study finds molecular switch key to repair of kidney damage

Researchers at Vanderbilt University Medical Center have identified Rac1, a molecular switch that regulates the actin cytoskeleton of epithelial cells in the collecting ducts, as a driver of post-obstructive kidney repair.
By Bill Snyder
December 5, 2023

Role of immunity in kidney injury hints at a potential therapy: study

Targeting the cytokine IL-22 could be a new therapeutic approach to prevent kidney injury caused by drugs or toxins, Vanderbilt researchers have discovered.
By Bill Snyder
December 4, 2023

New study uses genetic data to support use of thiazide diuretics for kidney stone prevention

A Vanderbilt University Medical Center genetic association study of more than 1 million adults supports the use of the common blood pressure medication thiazide diuretics for kidney stone prevention.
By Danny Bonvissuto
1 2 3 … 9